Drug Interaction Report

Siponimod and Buprenorphine: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Buprenorphine

Belbuca Brixadi Buprenex BuTrans Simbadol Sublocade Zorbium
+

Siponimod

Mayzent Mayzent®
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 79 documented Siponimod interactions, 78 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Buprenorphine and siponimod can both prolong the QT interval, and combining them may add up to raise arrhythmia risk. This combination is generally avoided, so talk with your doctor or pharmacist, who may involve a cardiologist and monitor your heart.

Both of these medicines can affect your heart's rhythm. Buprenorphine (a pain or addiction medicine) and siponimod (used for multiple sclerosis) can each stretch out a part of your heartbeat called the QT interval. When you take them together, that effect may add up, which in rare cases can lead to an irregular heartbeat.

This concern is based on how the drugs work rather than lots of real-world reports, but because it involves the heart, it's taken seriously. Please don't stop either medicine on your own. Talk with your doctor or pharmacist. Your care team can check your heart (often with an ECG), watch your heart rate, and decide the safest plan for you.

Additive QT prolongation. Buprenorphine and siponimod can each prolong the QT interval; concurrent use risks additive PD effects and increased arrhythmia (including torsades) potential. Siponimod also causes dose-dependent bradycardia at initiation, compounding concern.

  • Direction: additive QT effect; neither drug is a prodrug, so no activation-based reversal applies.
  • Evidence: theoretical/mechanistic; severity rated major.
  • Onset: unspecified; siponimod titration period is the key risk window.
  • Management: manufacturer advises against coadministration with known arrhythmogenic QT-prolonging drugs. If siponimod is required, obtain cardiology input regarding alternative agents or intensified monitoring (ECG, HR, electrolytes) at initiation.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

An increased risk of QT interval prolongation

Interaction Deep Dive

Because of possible additive impacts on heart rate, siponimod should not be given together with QT prolonging agents that have recognized arrhythmogenic properties. When siponimod therapy is being contemplated, consult a cardiologist about transitioning to medications that do not lower heart rate or about suitable monitoring when initiating treatment1.

Why it happens (mechanism)

Additive QT interval prolongation

How to manage this interaction

Keep taking both medicines exactly as prescribed unless your care team tells you otherwise, but do let them know you are on this combination.

  • Your prescriber may involve a cardiologist before starting or continuing siponimod.
  • They may check your heart with an ECG and monitor your heart rate, especially when siponimod is first started or its dose is being built up.
  • Your team may consider whether a different medicine that doesn't affect heart rate is an option for you.

Tell your pharmacist or doctor right away if you feel dizzy, faint, or notice a fast, slow, or fluttering heartbeat.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Siponimod and Buprenorphine together?

Buprenorphine and siponimod can both prolong the QT interval, and combining them may add up to raise arrhythmia risk. This combination is generally avoided, so talk with your doctor or pharmacist, who may involve a cardiologist and monitor your heart. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Siponimod and Buprenorphine interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Siponimod and Buprenorphine interaction managed?

Keep taking both medicines exactly as prescribed unless your care team tells you otherwise, but do let them know you are on this combination. Your prescriber may involve a cardiologist before starting or continuing siponimod. They may check your heart with an ECG and monitor your heart rate, especially when siponimod is first started or its dose is being built up. Your team may consider whether a… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Siponimod or Buprenorphine need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Product Information: MAYZENT(R) oral tablets, siponimod oral tablets. Novartis Pharmaceuticals Corporation (per FDA), East Hanover, NJ, 2019. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.